Targeted CRISPR knockout screening identifies known and novel chemogenomic interactions between DNA damaging agents

Collin D Heer1, James L Elia2, Vijay Menon1

  • 1Department of Therapeutic Radiology, Yale University, New Haven, CT 06510, United States.

NAR Cancer
|January 12, 2026
PubMed

Insights

This study maps the complex interactions between DNA damage repair (DDR) genes and DNA-damaging agents (DDAs) using CRISPR screening. Researchers uncovered novel DDR-DDA relationships, advancing cancer therapy insights.

Area of Science:

  • Genetics
  • Cancer Biology
  • Molecular Biology

Background:

  • Genetic instability, driven by DNA damage repair (DDR) gene mutations, is central to cancer development.
  • While DDR pathways are understood, the full chemogenomic landscape of DNA-damaging agent (DDA) interactions remains largely unmapped.
  • The chemical diversity of DDAs and the complexity of DDR networks necessitate comprehensive interaction mapping.

Purpose of the Study:

  • To systematically map the chemogenomic interactions between DDR genes and DDAs.
  • To identify novel DDR-DDA relationships using a high-throughput screening approach.
  • To understand the specific roles of DDR pathways in response to various DNA-damaging agents.

Main Methods:

  • Developed and employed a DDR-targeted CRISPR knockout screening strategy.
  • Assessed interactions between 353 DNA repair genes and 15 distinct DDAs in LN229 glioma cells.
  • Analyzed a dataset comprising 5295 DDR-related chemogenomic interactions.

Main Results:

  • Identified numerous established and novel DDR-DDA interactions.
  • Revealed a specific role for transcription-coupled nucleotide excision repair in repairing alkylating agent adducts.
  • Demonstrated pathway-specific repair dependencies, including the Fanconi anemia pathway for methyl lesions and distinct double-strand break repair following topoisomerase poison treatment.
  • Uncovered repair dependencies for imidazotetrazine drugs like temozolomide.

Conclusions:

  • The study provides a comprehensive map of DDR-DDA chemogenomic interactions, revealing novel functional relationships.
  • Findings highlight specific DDR pathway involvements in repairing diverse DNA lesions induced by various agents.
  • Uncovered interactions offer potential targets for developing novel cancer therapies and improving existing treatments.

Related Concept Videos

Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
62.5K
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.6K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.6K